Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
06/2013
06/04/2013US8455479 Heterocyclic compounds
06/04/2013US8455477 Therapeutic compounds
06/04/2013CA2545660C Heterocyclic inhibitors of mek and methods of use thereof
06/04/2013CA2545659C Bicyclic inhibitors of mek
06/01/2013CA2760174A1 Protein kinase inhibitors and uses thereof
05/2013
05/30/2013WO2013078254A1 Bicyclic heteroaryl derivatives as kinase inhibitors
05/30/2013WO2013077406A1 Aromatic amine derivative, material for organic electroluminescent element, and organic electroluminescent element
05/30/2013WO2013077345A1 Organic electroluminescent element, and light emitting device, display device and lighting device each using organic electroluminescent element
05/30/2013WO2013077344A1 Organic electroluminescent element, material for organic electroluminescent element, light emitting device, display device and lighting device each using said element, and compound used for said element
05/30/2013WO2013076182A1 [1, 2, 3]triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 agonists
05/30/2013WO2013075680A1 A method for the preparation and isolation of salts of vardenafil with acids
05/30/2013US20130137852 Novel compounds as dpp-iv inhibitors and process for preparation thereof
05/30/2013US20130137709 Compounds that modulate EGFR activity and methods for treating or preventing conditions therewith
05/30/2013US20130137708 Methods and compositions for kinase inhibition
05/30/2013US20130137707 Pyrazolopyrimidine pde 10 inhibitors
05/30/2013US20130137700 Fused heterocyclic ring compound
05/30/2013US20130137696 3,4-dihydro-2h-pyrrolo[1,2-a]pyrazin-1-one derivatives for the modulation of the activity of protein kinases
05/30/2013US20130137694 Novel modulators of nrf2 and uses thereof
05/30/2013US20130137681 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS
05/30/2013US20130137680 Heterocyclic compounds containing a pyrrolopyridine or benzimidazole core
05/30/2013US20130137676 Novel [1,2,3]triazolo[4,5-d]pyrimidine derivatives
05/30/2013US20130137672 DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORS
05/30/2013US20130137661 Gonadotropin Releasing Hormone Receptor Antagonist, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same
05/30/2013US20130137659 Anticancer derivatives, preparation thereof and therapeutic use thereof
05/30/2013CA2850697A1 [1, 2, 3]triazolo [4 , 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 agonists
05/30/2013CA2846496A1 Substituted pyrazolo[3,4-d]pyrimidines and uses thereof
05/29/2013EP2597098A1 (7h-pyrrolo [2, 3-d] pyrimidin-4-yl) -piperazines as kinase inhibitors for the treatment of cancer and inflammation
05/29/2013EP2597097A1 Substituted indoles, antiviral active component, method for producing and using same
05/29/2013EP2597089A1 Tricyclic heterocyclic compounds
05/29/2013EP2596793A1 Quinoline derivatives as PI3 kinase inhibitors
05/29/2013EP2595993A2 Tricyclic proteasome activity enhancing compounds
05/29/2013EP2595987A1 New aminopyrazoloquinazolines
05/29/2013EP2595983A1 2,3,5-trisubstituted thiophene compounds and uses thereof
05/29/2013EP2595632A1 Noribogaine compositions
05/29/2013EP2595483A1 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
05/29/2013CN1976934B Alkyl substituted indoloquinoxalines
05/29/2013CN103124731A Fused heteroaryls and their uses
05/29/2013CN103122004A Naphthoquinone compound with antitumor activity
05/29/2013CN103122003A Naphthoquinone compound with antitumor activity
05/29/2013CN103122002A Naphthoquinone compound with antitumor activity
05/29/2013CN103122001A Polo-like kinase inhibitors
05/29/2013CN103122000A High-selectivity c-Met kinase inhibitor used as antitumor drug
05/29/2013CN103121999A Method for synthesizing tyrosine kinase inhibitor PCI-32765
05/29/2013CN102318101B Material for phosphorescent light-emitting element and organic electroluminescent element using same
05/29/2013CN102267999B Flumazenil compound and preparation method thereof
05/29/2013CN101909628B Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolase
05/29/2013CN101646674B Indolobenzazepine derivatives for the treatment of hepatitis c
05/29/2013CN101641093B Imidazotriazines and imidazopyrimidines as kinase inhibitors
05/29/2013CN101553491B Quinoxaline derivative
05/29/2013CN101090902B Cgrp受体拮抗剂 Cgrp receptor antagonist
05/28/2013US8450480 Benzoxazole kinase inhibitors and methods of use
05/28/2013US8450479 3-substituted-4-oxo-3,4-dihydro-imidazo[5,1-d][1,2,3,5-tetrazine-8-carboxylic acid amides and their use
05/28/2013US8450477 Process for the manufacture of bridged monobactam intermediates
05/28/2013US8450341 Substituted indolin-2-one derivatives and their use as P38 mitogen-activated kinase inhibitors
05/28/2013US8450331 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their use
05/28/2013US8450329 Benzoxazole kinase inhibitors and methods of use
05/28/2013US8450322 Substituted imidazo[1,2b]pyridazine compounds as Trk kinase inhibitors
05/28/2013US8450319 Pyrrolopyridazinone compound
05/28/2013US8450308 Inhibitors of beta-secretase
05/28/2013CA2740262C 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
05/28/2013CA2720946C Compounds and compositions as protein kinase inhibitors
05/28/2013CA2576765C Pyridine methylene azolidinones and use thereof phosphoinositide inhibitors
05/28/2013CA2573688C (1s,5s)-3-(5,6-dichloro-3-pyridinyl)-3,6-diazabicyclo[3.2.0]heptane
05/28/2013CA2562693C Reverse-turn mimetics and method relating thereto
05/28/2013CA2553243C Pyrrolo pyrimidine derivatives useful for treating proliferative diseases
05/28/2013CA2547887C Protein modifier production inhibitor
05/28/2013CA2530886C Dual nk1/nk3 antagonists for treating schizophrenia
05/23/2013WO2013073577A1 Dihydroxy aromatic heterocyclic compound
05/23/2013WO2013072678A1 Separation technique, photo-oxidation of organic substrates, and photo catalysts
05/23/2013WO2013072491A1 Methods for preparing functional tetraazacycloalkane compounds using a specific cyclic bisaminal compound
05/23/2013WO2013072015A1 Morpholinyl benzotriazine for use in cancer therapy
05/23/2013WO2013071697A1 Aminoquinazoline derivatives and their salts and methods of use
05/23/2013US20130131336 Carbazole linked pyrrolo[2,1-c][1,4]benzodiazefine hybrids as potential anticancer agents and process for the preparation thereof
05/23/2013US20130131321 LIGANDS FOR ANTIBODY AND Fc-FUSION PROTEIN PURIFICATION BY AFFINITY CHROMATOGRAPHY
05/23/2013US20130131087 Pharmaceutical Compositions
05/23/2013US20130131068 Phthalazinone ketone derivative, preparation method thereof, and pharmaceutical use thereof
05/23/2013US20130131057 New bicyclic compounds as pi3-k and mtor inhibitors
05/23/2013US20130131050 Fused heterocyclic compound and application thereof
05/23/2013US20130131043 Pyrazole compounds as jak inhibitors
05/23/2013US20130131041 Spirocyclic compounds
05/23/2013US20130131039 5,7-substituted-imidazo[1,2-c]pyrimidines as inhibitors of jak kinases
05/23/2013US20130131034 Derivatives of aminoindanes, their preparation and their application in therapeutics
05/23/2013US20130130974 NOVEL SYNTHETIC APPROACH TO beta-AMINOBUTYRYL SUBSTITUTED COMPOUNDS
05/23/2013US20130130289 Compounds and methods for assaying redox state of metabolically active cells and methods for measuring nad(p)/nad(p)h
05/23/2013US20130130277 Remedy for diabetes
05/23/2013CA2856103A1 Morpholinyl benzotriazine for use in cancer therapy
05/23/2013CA2855868A1 Methods for preparing functional tetraazacycloalkane compounds using a specific cyclic bisaminal compound
05/23/2013CA2851151A1 Aminoquinazoline derivatives and their salts and methods of use
05/22/2013EP2594567A1 Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof
05/22/2013EP2593461A1 Compounds for the reduction of beta-amyloid production
05/22/2013EP2593460A1 7, 9-nitrogen radical-4-oxo-4h-pyrido[l,2-a]pyrimidine-2-carboxylic acid benzylamide anti-virals
05/22/2013EP2593459A1 Process for the preparation of organic salts
05/22/2013EP2593458A1 Bicyclic pyrimidines
05/22/2013EP2593457A1 Pyrazolo [1, 5a]pyrimidine and thieno [3, 2b]pyrimidine derivatives as irak4 modulators
05/22/2013EP2593456A1 Aldose reductase inhibitors and uses thereof
05/22/2013EP2593451A2 Substituted imidazo[1,2-a]pyrimidines and -pyridines
05/22/2013EP2593432A1 N-sulfonylbenzamide derivatives useful as voltage gated sodium channel inhibitors
05/22/2013CN103119047A Tricyclic proteasome activity enhancing compounds
05/22/2013CN103119046A Fusing porphyrins with polycyclic aromatic hydrocarbons and heterocycles for optoelectric applications
05/22/2013CN103119045A Pyrrolopyrimidine compounds and uses thereof
1 ... 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 ... 573